The estimated Net Worth of David R. Wells is at least $473 ezer dollars as of 5 January 2021. Mr. Wells owns over 35,000 units of ENDRA Life Sciences Inc stock worth over $20,001 and over the last 8 years he sold NDRA stock worth over $31,500. In addition, he makes $421,749 as Chief Financial Officer at ENDRA Life Sciences Inc.
Sign up
Mr. Wells NDRA stock SEC Form 4 insiders trading
David has made over 3 trades of the ENDRA Life Sciences Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 35,000 units of NDRA stock worth $31,500 on 5 January 2021.
The largest trade he's ever made was selling 35,000 units of ENDRA Life Sciences Inc stock on 5 January 2021 worth over $31,500. On average, David trades about 3,929 units every 36 days since 2017. As of 5 January 2021 he still owns at least 80,003 units of ENDRA Life Sciences Inc stock.
You can see the complete history of Mr. Wells stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
David Wells biography
David R. Wells serves as Chief Financial Officer of the Company. He possesses over 30 years of experience in finance, operations and administrative positions. While mainly focused on technology companies, Mr. Wells has also worked in the water treatment, supply-chain management, manufacturing and professional services industries. Mr. Wells is the founder of Wells Compliance Group, a technology-based services firm supporting the financial reporting needs of publicly traded companies and privately held firms whose investor or shareholder base requires timely GAAP-compliant financial reporting. Through StoryCorp Consulting (d/b/a/ Wells Compliance Group), Mr. Wells consults with several emerging growth companies. From 2009 to 2013, he was the President, CFO and a Director of Sionix Corporation, a publicly traded water treatment company. Mr. Wells holds an MBA from Pepperdine University and a BS in Finance and Entrepreneurship from Seattle Pacific University.
What is the salary of David Wells?
As the Chief Financial Officer of ENDRA Life Sciences Inc, the total compensation of David Wells at ENDRA Life Sciences Inc is $421,749. There are 2 executives at ENDRA Life Sciences Inc getting paid more, with Francois Michelon having the highest compensation of $978,776.
How old is David Wells?
David Wells is 57, he's been the Chief Financial Officer of ENDRA Life Sciences Inc since 2017. There are 3 older and 6 younger executives at ENDRA Life Sciences Inc. The oldest executive at ENDRA Life Sciences Inc is Michael Harsh, 65, who is the Independent Director.
What's David Wells's mailing address?
David's mailing address filed with the SEC is 3600 GREEN COURT, SUITE 350, , ANN ARBOR, MI, 48105.
Insiders trading at ENDRA Life Sciences Inc
Over the last 8 years, insiders at ENDRA Life Sciences Inc have traded over $893,199 worth of ENDRA Life Sciences Inc stock and bought 413,648 units worth $301,877 . The most active insiders traders include Group Ag Ubs, Capital Advisors, Llc Conra... és Alexander Y Tokman. On average, ENDRA Life Sciences Inc executives and independent directors trade stock every 61 days with the average trade being worth of $5,922. The most recent stock trade was executed by Group Ag Ubs on 27 August 2024, trading 3,715 units of NDRA stock currently worth $2,043.
What does ENDRA Life Sciences Inc do?
endra life sciences is bringing new capabilities to ultrasound. our photo-acoustic solutions help medical researchers screen and modify disease models with unparalleled quality and speed. we’re proud to have a global installed base of leading institutions using our nexus-128 system, the only 3d imaging solution for imaging anatomy, physiology and labeled molecular targets. the nexus 128 is a preclinical photoacoustic computed tomography (ct) scanner for small animal imaging. the system is used for simple, fast, non-invasive quantification of physiological parameters such as tumor vasculature without ionizing radiation. the fully-3d imaging technology used by the nexus 128 provides increased sensitivity compared to slice-based scanners, and dynamic (4-d) photoacoustic ct scans allow for applications such as quantification of probe uptake. the nexus 128 is currently being used by top imaging laboratories around the globe.
What does ENDRA Life Sciences Inc's logo look like?
Complete history of Mr. Wells stock trades at ENDRA Life Sciences Inc
ENDRA Life Sciences Inc executives and stock owners
ENDRA Life Sciences Inc executives and other stock owners filed with the SEC include:
-
Francois Michelon,
Chairman of the Board, Chief Executive Officer -
Michael Thornton,
Chief Technology Officer -
David Wells,
Chief Financial Officer -
Michael Thornton,
Chief Technology Officer -
David R. Wells,
CFO & Sec. -
Joe Hassett,
Investors Relation -
Louis Basenese,
Independent Director -
Alexander Tokman,
Independent Director -
Michael Harsh,
Independent Director -
Sanjiv Gambhir,
Independent Director -
Anthony DiGiandomenico,
Independent Director -
Renaud Maloberti,
Chief Commercial Officer -
Steve Freeman,
HR Leader -
Dr. Jonathan Behr,
Co-Founder -
Capital Advisors, Llc Conra...,
-
Group Ag Ubs,
10% owner -
Lou Basenese,
Director -
Irina Pestrikova,
Senior Director, Finance